1. Home
  2. DK vs TARS Comparison

DK vs TARS Comparison

Compare DK & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DK
  • TARS
  • Stock Information
  • Founded
  • DK 2001
  • TARS 2016
  • Country
  • DK United States
  • TARS United States
  • Employees
  • DK N/A
  • TARS N/A
  • Industry
  • DK Integrated oil Companies
  • TARS Medicinal Chemicals and Botanical Products
  • Sector
  • DK Energy
  • TARS Health Care
  • Exchange
  • DK Nasdaq
  • TARS Nasdaq
  • Market Cap
  • DK 1.6B
  • TARS 1.7B
  • IPO Year
  • DK 2006
  • TARS 2020
  • Fundamental
  • Price
  • DK $31.32
  • TARS $57.63
  • Analyst Decision
  • DK Hold
  • TARS Strong Buy
  • Analyst Count
  • DK 12
  • TARS 7
  • Target Price
  • DK $24.50
  • TARS $67.14
  • AVG Volume (30 Days)
  • DK 2.3M
  • TARS 630.9K
  • Earning Date
  • DK 08-06-2025
  • TARS 08-06-2025
  • Dividend Yield
  • DK 3.20%
  • TARS N/A
  • EPS Growth
  • DK N/A
  • TARS N/A
  • EPS
  • DK N/A
  • TARS N/A
  • Revenue
  • DK $10,822,600,000.00
  • TARS $295,521,000.00
  • Revenue This Year
  • DK N/A
  • TARS $33,170.29
  • Revenue Next Year
  • DK N/A
  • TARS N/A
  • P/E Ratio
  • DK N/A
  • TARS N/A
  • Revenue Growth
  • DK N/A
  • TARS 254.45
  • 52 Week Low
  • DK $11.03
  • TARS $27.18
  • 52 Week High
  • DK $32.48
  • TARS $59.76
  • Technical
  • Relative Strength Index (RSI)
  • DK 74.43
  • TARS 69.92
  • Support Level
  • DK $21.09
  • TARS $57.00
  • Resistance Level
  • DK $32.48
  • TARS $59.76
  • Average True Range (ATR)
  • DK 1.65
  • TARS 1.74
  • MACD
  • DK 0.87
  • TARS -0.26
  • Stochastic Oscillator
  • DK 89.82
  • TARS 67.78

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has two segments: Refining segment and Logistics segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: